Trinity Biotech (TRIB) Non-Current Assets (2009 - 2025)

Trinity Biotech's Non-Current Assets history runs 17 years deep, the most recent figure standing at $69.3 million for Q4 2025.

• In Q4 2025, Non-Current Assets rose 11.42% year-over-year to $69.3 million; the TTM figure through Dec 2025 stood at $69.3 million (up 11.42% YoY), while the FY2025 annual figure was $69.3 million, up 11.42% from the prior year.
• Non-Current Assets came in at $69.3 million for Q4 2025 at Trinity Biotech, up from $66.6 million in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $69.3 million in Q4 2025 to a low of $19.1 million in Q2 2023.
• A 5-year average of $44.9 million and a median of $47.0 million in 2021 frame the typical range for Non-Current Assets.
• Across the five-year window, Non-Current Assets tumbled 61.78% in 2023 and surged 204.82% in 2024, its largest moves.
• Trinity Biotech's Non-Current Assets stood at $46.2 million in 2021, then fell by 1.67% to $45.4 million in 2022, then tumbled by 55.11% to $20.4 million in 2023, then soared by 204.82% to $62.2 million in 2024, then advanced by 11.42% to $69.3 million in 2025.
• According to Business Quant data, Non-Current Assets over the past three periods registered $69.3 million, $66.6 million, and $62.2 million for Q4 2025, Q2 2025, and Q4 2024 respectively.

Peer Comparison